Our stock incentive plans are administered by the Compensation Committee of the Board of Directors and have been approved by the stockholders of the Company. The terms and conditions of our share-based awards are determined by the Compensation Committee for each award date and may include provisions for the exercise price, expirations, vesting, restriction on sales, and forfeitures, as applicable. We issue new shares to satisfy stock issuances under our stock incentive plans.

Our Amended and Restated 2004 Stock Incentive Plan authorizes the issuance of up to 11,600,000 common shares in connection with the granting of stock options, stock appreciation rights, restricted stock purchase rights, restricted stock bonuses, restricted stock units, or performance units to key employees, directors, and other designated employees. There were 1,677,983 shares of common stock available for future issuance under this plan as of September 29, 2019.

We also maintain a deferred compensation plan for non-management directors under which those who are eligible to receive fees or retainers may choose to defer receipt of their compensation. The deferred amounts are converted to stock equivalents. The plan requires settlement in shares of our common stock based on the number of stock equivalents and dividend equivalents at the time of a participant’s separation from the Board of Directors. This plan provides for the issuance of up to 350,000 shares of common stock in connection with the crediting of stock equivalents. There were 143,122 shares of common stock available for future issuance under this plan as of September 29, 2019.

Compensation expense — The components of share-based compensation expense, included within “Selling, general, and administrative expenses” in our consolidated statement of earnings, in each fiscal year are as follows (in thousands):



	2019		2018		2017
Nonvested stock units	$	5,458	$	5,737	$	5,873
Stock options	936		1,790		1,826
Performance share awards	1,417		1,236		2,580
Nonvested restricted stock awards	—		33		88
Non-management directors’ deferred compensation	263		350		270
Total share-based compensation expense	$	8,074	$	9,146	$	10,637

Nonvested restricted stock units — Nonvested restricted stock units (“RSUs”) are generally issued to executives, non-management directors and certain other members of management and employees. Prior to fiscal 2011, RSUs were granted to certain Executive and Senior Vice Presidents pursuant to our share ownership guidelines. These awards vest upon retirement or termination based on years of service. There were 60,272 of such RSUs outstanding as of September 29, 2019.

Beginning fiscal 2011, we replaced the ownership share grants with time-vested RSUs for certain Vice Presidents and Officers that vest ratably over four to five years and have a 50% or 100% holding requirement on settled shares, which must be held until termination. There were 146,268 of such RSUs outstanding as of September 29, 2019. RSUs issued to non-management directors and certain other employees vest 12 months from the date of grant, or upon termination of board service if the director or employee elects to defer receipt, and totaled 69,411 units outstanding as of September 29, 2019. RSUs issued to certain other employees either cliff vest or vest ratably over three years and totaled 35,864 units outstanding as of September 29, 2019. These awards are amortized to compensation expense over the estimated vesting period based upon the fair value of our common stock on the award date discounted by the present value of the expected dividend stream over the vesting period.



	Shares		Weighted- Average Grant Date Fair Value
RSUs outstanding at September 30, 2018	288,098		$	64.57
Granted	93,686		$	86.08
Released	(55,642	)	$	84.23
Forfeited	(14,297	)	$	94.00
RSUs outstanding at September 29, 2019	311,845		$	66.18

As of September 29, 2019, there was approximately $7.4 million of total unrecognized compensation cost related to RSUs, which is expected to be recognized over a weighted-average period of 2.2 years. The weighted-average grant date fair value of awards granted was $86.08, $94.93, and $102.42 in fiscal years 2019, 2018, and 2017, respectively. In fiscal years 2019, 2018, and 2017, the total fair value of RSUs that vested and were released was $4.7 million, $4.4 million, and $4.4 million, respectively.

Stock options — Option grants have contractual terms of seven years and employee options vest over a three-year period. Options may vest sooner upon retirement from the Company for employees meeting certain age and years of service thresholds. All option grants provide for an option exercise price equal to the closing market value of the common stock on the date of grant.



	Shares		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value (in thousands)
Options outstanding at September 30, 2018	287,618		$	87.61
Granted	—		N/A
Exercised	(20,074	)	$	61.28
Forfeited	(303	)	$	90.06
Expired	(683	)	$	104.95
Options outstanding at September 29, 2019	266,558		$	89.54	4.25	$	1,334
Options exercisable at September 29, 2019	176,179		$	87.56	3.80	$	1,307
Options exercisable and expected to vest at September 29, 2019	266,558		$	89.54	4.25	$	1,334

We use a valuation model to determine the fair value of options granted that requires the input of highly subjective assumptions, including the expected volatility of the stock price. The following table presents the weighted-average assumptions used for stock option grants in each fiscal year, along with the related weighted-average grant date fair value:



	2019	2018	2017
Risk-free interest rate	N/A	2.4%	1.4%
Expected dividends yield	N/A	1.8%	1.5%
Expected stock price volatility	N/A	28.8%	29.0%
Expected life of options (in years)	N/A	3.40	3.50
Weighted-average grant date fair value	N/A	$18.49	$20.92

The risk-free interest rate was determined by a yield curve of risk-free rates based on published U.S. Treasury spot rates in effect at the time of grant and has a term equal to the expected life of the related options. The dividend yield assumption is based on the Company’s history and expectations of dividend payouts at the grant date. The expected stock price volatility in all years represents the Company’s historical volatility. The expected life of the options represents the period of time the options are expected to be outstanding and is based on historical trends.

As of September 29, 2019, there was approximately $0.6 million of total unrecognized compensation cost related to stock options grants that is expected to be recognized over a weighted-average period of 1 year. The total intrinsic value of stock options exercised was $0.5 million, $2.3 million, and $6.9 million in fiscal years 2019, 2018, and 2017, respectively.

Performance share awards — Performance share awards, granted in the form of stock units, represent a right to receive a certain number of shares of common stock based on the achievement of corporate performance goals and continued employment during the vesting period. Performance share awards issued to executives vest at the end of a three-year period and vested amounts may range from 0% to a maximum of 150% of targeted amounts depending on the achievement of performance measures at the end of a three-year period. If the awardee ceases to be employed by the Company prior to the last day of the performance period due to retirement, disability, or death, the performance share awards become vested pro-rata based on the number of full accounting periods the awardee was continuously employed by the Company. The expected cost of the shares is based on the fair value of our stock on the date of grant and is reflected over the vesting period with a reduction for estimated forfeitures. These awards may be settled in cash or shares of common stock at the election of the Company on the date of grant. It is our intent to settle these awards with shares of common stock.



	Shares		Weighted- Average Grant Date Fair Value
Performance share awards outstanding at September 30, 2018	52,479		$	83.21
Granted	45,113		$	84.60
Issued	(18,695	)	$	83.56
Forfeited	(687	)	$	91.91
Performance adjustments	(2,720	)	$	97.51
Performance share awards outstanding at September 29, 2019	75,490		$	83.40

As of September 29, 2019, there was approximately $2.0 million of total unrecognized compensation cost related to performance share awards, which is expected to be recognized over a weighted-average period of 1.8 years. The weighted-average grant date fair value of awards granted was $84.60, $97.02, and $95.33 in fiscal years 2019, 2018, and 2017, respectively. The total fair value of awards that became fully vested during fiscal years 2019, 2018, and 2017 was $2.1 million, $1.6 million, and $3.2 million, respectively.

Nonvested stock awards — We previously issued nonvested stock awards (“RSAs”) to certain executives under our share ownership guidelines. Effective fiscal 2009, we no longer issue RSA awards and replaced them with grants of RSUs. The RSAs vest, subject to the discretion of our Board of Directors in certain circumstances, upon retirement or termination based upon years of service. These awards are amortized to compensation expense over the estimated vesting period based upon the fair value of our common stock on the award date. As of September 29, 2019, RSAs outstanding totaled 33,243 shares with a weighted-average grant date fair value of $26.47 per share.

Non-management directors’ deferred compensation — All awards outstanding under our directors’ deferred compensation plan are accounted for as equity-based awards and deferred amounts are converted into stock equivalents based on a per share price equal to the average of the closing price of our common stock for the 10 trading days immediately preceding the date the deferred compensation is credited to the director’s account. During fiscal years 2019, 2018, and 2017 no common stock was issued in connection with director retirements.



	Stock Equivalents	Weighted- Average Grant Date Fair Value
Stock equivalents outstanding at September 30, 2018	94,390	$	36.35
Deferred directors’ compensation	3,277	$	79.95
Dividend equivalents	2,338	$	82.87
Stock equivalents outstanding at September 29, 2019	100,005	$	38.87